You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ozanimod

Showing 1 - 25 of 48
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ozanimod Exposure During Pregnancy in Multiple Sclerosis and

Active, not recruiting
  • Multiple Sclerosis
  • Ozanimod
  • +2 more
  • Eden Prairie, Minnesota
    OptumInsight Life Sciences Inc
Nov 9, 2023

Ulcerative Colitis Trial

Not yet recruiting
  • Ulcerative Colitis
    • (no location specified)
    Jul 12, 2023

    Assess Safety of Ozanimod in Moderate to Severe Active UC in

    Not yet recruiting
    • Ulcerative Colitis
    • Ozanimod
    • Seoul, Korea, Republic of
      Bristol-Myers Squibb YH
    Oct 3, 2023

    Ozanimod Exposure During Pregnancy in Ulcerative Colitis and

    Not yet recruiting
    • Ulcerative Colitis
    • Ozanimod
    • +2 more
    • Eden Prairie, Minnesota
      OptumInsight Life Sciences Inc
    Nov 9, 2023

    Ozanimod in UC Discovering Biomarkers in Management of

    Not yet recruiting
    • Ulcerative Colitis
    • Ozanimod
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Apr 14, 2023

    Multiple Sclerosis Trial in Roma (Ozanimod Oral Capsule)

    Recruiting
    • Multiple Sclerosis
    • Ozanimod Oral Capsule
    • Roma, RM, Italy
      IRCCS Fondazione Santa Lucia
    Mar 9, 2023

    Relapsing-Remitting Multiple Sclerosis (RRMS) Participants

    Not yet recruiting
    • Relapsing-remitting Multiple Sclerosis (RRMS)
      • (no location specified)
      Apr 11, 2023

      A Post-Authorization, Long-term Study of Ozanimod Real-world

      Active, not recruiting
      • Multiple Sclerosis, Relapsing-Remitting
        • Bethesda, Maryland
          Evidera
        Oct 31, 2022

        Quality of Life of Ozanimod in Ulcerative Colitis

        Recruiting
        • Colitis, Ulcerative
        • Ozanimod
        • Berlin, Germany
          Local Institution - 0001
        Jun 28, 2022

        Multiple Sclerosis Trial run by the

        Recruiting
        • Multiple Sclerosis
          • Bethesda, Maryland
            Evidera
          Jun 2, 2022

          Ozanimod on Fatigue in Multiple Sclerosis Patients

          Not yet recruiting
          • Fatigue
          • Multiple Sclerosis
          • Ozanimod
          • (no location specified)
          Apr 15, 2022

          Describe Switching FromFirst- or Second-line Disease Modifying

          Not yet recruiting
          • Multiple Sclerosis, Relapsing-Remitting
            • (no location specified)
            Dec 12, 2022

            Crohn Disease Trial in Cleveland, Miskolc, Madrid (Ozanimod)

            Not yet recruiting
            • Crohn Disease
            • Ozanimod
            • Cleveland, Ohio
            • +2 more
            Jul 21, 2022

            Ulcerative Colitis Trial in China, Taiwan (Ozanimod, Placebo)

            Recruiting
            • Ulcerative Colitis
            • Ozanimod
            • Placebo
            • WuHu, Anhui, China
            • +18 more
            Jan 9, 2023

            Liver Diseases, Digestive System Diseases Trial in Miami, Orlando, San Antonio (Ozanimod)

            Completed
            • Liver Diseases
            • Digestive System Diseases
            • Ozanimod
            • Miami, Florida
            • +2 more
            Jun 13, 2022

            Quality of Life in Clinical Practice in Germany for

            Recruiting
            • Multiple Sclerosis, Relapsing-Remitting
              • Dresden, Saxony, Germany
                Universitätsklinikum Dresden, MS Ambulanz
              Apr 12, 2022

              Healthy Volunteers Trial in Austin (Ozanimod)

              Completed
              • Healthy Volunteers
              • Ozanimod
              • Austin, Texas
                PPD Phase 1 Clinic
              Sep 17, 2021

              Healthy Volunteers Trial in Anaheim (Placebo, Rasigiline, Phenelzine)

              Recruiting
              • Healthy Volunteers
              • Placebo
              • +3 more
              • Anaheim, California
                Anaheim Clinical Trials
              Oct 13, 2021

              Relationship Between Oral DMT Burden and Adherence in MS

              Enrolling by invitation
              • Multiple Sclerosis
              • Adherence, Medication
              • Melbourne, Victoria, Australia
                Monash University
              Aug 28, 2022

              Combined Microbiota and Metabolic Signature in Ulcerative

              Not yet recruiting
              • Ulcerative Colitis
              • Ozanimod
              • +4 more
              • (no location specified)
              Jan 26, 2023

              Neurodegeneration in Multiple Sclerosis -Preclinical Study

              Not yet recruiting
              • Relapsing-Remitting Multiple Sclerosis (RRMS)
              • +2 more
              • Peripheral blood withdrawal
              • Pozzilli, Isernia, Italy
              • +2 more
              Feb 15, 2022

              Colitis, Ulcerative Trial in Worldwide (Ozanimod)

              Recruiting
              • Colitis, Ulcerative
              • Ozanimod
              • Phoenix, Arizona
              • +48 more
              Oct 25, 2022

              Healthy Volunteer Trial in Beijing (Ozanimod)

              Completed
              • Healthy Volunteer
              • Ozanimod
              • Beijing, China
                Capital Medical University - Beijing Anzhen Hospital
              Mar 24, 2021

              Healthy Volunteers Trial in San Antonio (Ozanimod, Cyclosporine)

              Completed
              • Healthy Volunteers
              • San Antonio, Texas
                ICON Early Phase Services
              Aug 20, 2020

              Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting Trial in Germany, United States (Tetanus, diphtheria, and acellular

              Recruiting
              • Multiple Sclerosis
              • Multiple Sclerosis, Relapsing-Remitting
              • Tetanus, diphtheria, and acellular pertussis vaccine
              • +2 more
              • Palo Alto, California
              • +47 more
              Jun 24, 2022